GlassScriptPhysician profile
Chris J West
NPI 1265491112
$7,587.36
in general payments reported to CMS, 2019-2025
53 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $971 · 2021: $1,193 · 2022: $648 · 2023: $921 · 2024: $1,332 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,578 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,577.90 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,183.56 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $888.89 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $654.75 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $536.51 | 2019-2025 | Repatha, Evenity, Prolia |
| Allergan, INC. | $510.62 | 2019-2020 | |
| Pfizer INC. | $482.23 | 2019-2025 | |
| Lilly USA, LLC | $473.10 | 2019-2025 | Mounjaro, Zepbound |
| Antares Pharma, INC. | $305.60 | 2019-2025 | Xyosted |
| Glaxosmithkline, LLC. | $234.74 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Merck Sharp & Dohme LLC | $155.76 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Ibsa Pharma INC. | $144.03 | 2019-2025 | Flector, Tirosint, Licart |
| Globus Medical, INC. | $127.43 | 2025 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $126.95 | 2024-2025 | |
| Eisai INC. | $123.10 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.53 | 2019-2024 | Trintellix |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.